AMARIN CORP PLC\UK

AMRN ·Healthcare, Drug Manufacturers - General
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $73.6M $98.3M $107.0M $119.5M $191.5M $260.2M $116.6M $31.4M
Accounts Receivable $45.3M $20.0M $13.8M $7.8M $3.6M
Inventory $30.3M $20.5M $19.0M $13.7M $21.2M $21.3M
Total Current Assets $153.3M $146.3M $143.5M $145.3M $219.4M $285.7M $119.0M $33.1M
Property, Plant & Equipment $28.0K $78.0K $243.0K $381.0K $579.0K $811.0K $432.0K $88.0K
Goodwill
Intangible Assets (Excl. Goodwill) $8.1M $8.8M $9.4M $10.1M $10.7M $11.4M
Total Assets $161.6M $167.0M $173.2M $171.1M $252.5M $310.9M $126.4M $35.4M
Liabilities
Accounts Payable $25.2M $6.1M $10.8M $8.5M $6.4M $17.5M $4.4M $4.4M
Total Current Liabilities $108.5M $76.2M $50.7M $40.3M $37.5M $25.2M $8.5M $7.6M
Long-Term Debt $70.8M $85.2M $91.5M $89.6M $87.7M $85.2M
Total Liabilities $226.7M $176.1M $300.8M $259.6M $286.3M $314.9M $132.3M $237.7M
Stockholders' Equity
Retained Earnings $-1.27B $-1.20B $-1.12B $-970.2M $-913.9M $-747.6M $-568.5M $-499.3M
Total Stockholders' Equity $-65.1M $-9.1M $-129.2M $-88.4M $-33.9M $-4.0M $-6.0M $-202.4M
← Newer Page 2 of 3 Older →